NYSE:ACIC

Atlas Crest Investment Competitors

$10.01
-0.05 (-0.50 %)
(As of 04/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.00
Now: $10.01
$10.08
50-Day Range
$10.04
MA: $10.91
$14.87
52-Week Range
$9.73
Now: $10.01
$18.60
Volume1.09 million shs
Average Volume3.36 million shs
Market Capitalization$625.63 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Atlas Crest Investment (NYSE:ACIC) Vs. AJAX, AJAX, BTWN, CMLF, BOAC, and BOWX

Should you be buying ACIC stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Atlas Crest Investment, including Ajax I (AJAX), Ajax I (AJAX), Bridgetown (BTWN), CM Life Sciences (CMLF), Bluescape Opportunities Acquisition (BOAC), and BowX Acquisition (BOWX).

Ajax I (NYSE:AJAX) and Atlas Crest Investment (NYSE:ACIC) are both small-cap unclassified companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, institutional ownership, profitability and earnings.

Analyst Ratings

This is a breakdown of current recommendations for Ajax I and Atlas Crest Investment, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Atlas Crest Investment0000N/A

Valuation and Earnings

This table compares Ajax I and Atlas Crest Investment's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Atlas Crest InvestmentN/AN/AN/AN/AN/A

Profitability

This table compares Ajax I and Atlas Crest Investment's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Atlas Crest InvestmentN/AN/AN/A

Atlas Crest Investment (NYSE:ACIC) and Ajax I (NYSE:AJAX) are both small-cap unclassified companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

Earnings and Valuation

This table compares Atlas Crest Investment and Ajax I's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlas Crest InvestmentN/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Profitability

This table compares Atlas Crest Investment and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Atlas Crest InvestmentN/AN/AN/A
Ajax IN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Atlas Crest Investment and Ajax I, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Atlas Crest Investment0000N/A
Ajax I0000N/A

Bridgetown (NASDAQ:BTWN) and Atlas Crest Investment (NYSE:ACIC) are both small-cap unclassified companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership and valuation.

Earnings & Valuation

This table compares Bridgetown and Atlas Crest Investment's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgetownN/AN/AN/AN/AN/A
Atlas Crest InvestmentN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Bridgetown and Atlas Crest Investment, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bridgetown0000N/A
Atlas Crest Investment0000N/A

Profitability

This table compares Bridgetown and Atlas Crest Investment's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BridgetownN/AN/AN/A
Atlas Crest InvestmentN/AN/AN/A

Atlas Crest Investment (NYSE:ACIC) and CM Life Sciences (NASDAQ:CMLF) are both small-cap unclassified companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation and institutional ownership.

Valuation & Earnings

This table compares Atlas Crest Investment and CM Life Sciences' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlas Crest InvestmentN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and target prices for Atlas Crest Investment and CM Life Sciences, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Atlas Crest Investment0000N/A
CM Life Sciences0000N/A

Profitability

This table compares Atlas Crest Investment and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Atlas Crest InvestmentN/AN/AN/A
CM Life SciencesN/AN/AN/A

Bluescape Opportunities Acquisition (NYSE:BOAC) and Atlas Crest Investment (NYSE:ACIC) are both small-cap unclassified companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings.

Earnings & Valuation

This table compares Bluescape Opportunities Acquisition and Atlas Crest Investment's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A
Atlas Crest InvestmentN/AN/AN/AN/AN/A

Profitability

This table compares Bluescape Opportunities Acquisition and Atlas Crest Investment's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bluescape Opportunities AcquisitionN/AN/AN/A
Atlas Crest InvestmentN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for Bluescape Opportunities Acquisition and Atlas Crest Investment, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bluescape Opportunities Acquisition0000N/A
Atlas Crest Investment0000N/A

BowX Acquisition (NASDAQ:BOWX) and Atlas Crest Investment (NYSE:ACIC) are both small-cap unclassified companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Analyst Recommendations

This is a breakdown of current ratings for BowX Acquisition and Atlas Crest Investment, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BowX Acquisition0000N/A
Atlas Crest Investment0000N/A

Earnings & Valuation

This table compares BowX Acquisition and Atlas Crest Investment's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BowX AcquisitionN/AN/AN/AN/AN/A
Atlas Crest InvestmentN/AN/AN/AN/AN/A

Profitability

This table compares BowX Acquisition and Atlas Crest Investment's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BowX AcquisitionN/AN/AN/A
Atlas Crest InvestmentN/AN/AN/A


Atlas Crest Investment Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$10.11-0.3%$904.27 millionN/A0.00Increase in Short Interest
Ajax I logo
AJAX
Ajax I
0.0$10.11-0.3%$904.27 millionN/A0.00Increase in Short Interest
BTWN
Bridgetown
0.0$10.68-1.3%$794.31 millionN/A0.00
CMLF
CM Life Sciences
0.0$13.98-2.8%$773.71 millionN/A0.00
BOAC
Bluescape Opportunities Acquisition
0.0$10.11-0.9%$767.73 millionN/A0.00Decrease in Short Interest
BOWX
BowX Acquisition
0.0$12.45-8.8%$751.67 millionN/A0.00Increase in Short Interest
VYGG
Vy Global Growth
0.0$10.38-0.4%$743.19 millionN/A0.00
TPGY
TPG Pace Beneficial Finance
0.3$16.06-5.5%$702.63 millionN/A0.00
HZON
Horizon Acquisition Co. II
0.0$10.22-0.9%$671.56 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.42-0.2%$670.79 millionN/A0.00News Coverage
MIT
Mason Industrial Technology
0.0$9.85-0.2%$615.63 millionN/A0.00News Coverage
VSPR
Vesper Healthcare Acquisition
1.7$10.55-0.8%$602.03 millionN/A0.00Analyst Report
Decrease in Short Interest
HAAC
Health Assurance Acquisition
0.0$10.67-1.4%$590.85 millionN/A0.00
KVSC
Khosla Ventures Acquisition Co. III
0.0$10.15-0.0%$571.16 millionN/A0.00
VAQC
Vector Acquisition Corp II
0.0$10.00-0.5%$570.63 millionN/A0.00Quiet Period Expiration
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.05-0.0%$565.31 millionN/A0.00
CFII
CF Finance Acquisition Corp. II
0.3$8.39-2.5%$533.60 millionN/A0.00Increase in Short Interest
News Coverage
MUDS
Mudrick Capital Acquisition Co. II
0.0$13.24-0.9%$528.13 millionN/A0.00High Trading Volume
Unusual Options Activity
MAAC
Montes Archimedes Acquisition
0.0$9.92-0.7%$517.57 millionN/A0.00
MOTV
Motive Capital
0.0$9.92-0.6%$516.47 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.86-0.7%$513.88 millionN/A0.00News Coverage
DGNU
ArcLight Clean Transition Corp. II Unit
0.0$10.20-0.4%$508 millionN/A0.00
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.90-0.6%$503.94 millionN/A0.00
SPNV
Supernova Partners Acquisition
0.0$9.99-0.2%$502.63 millionN/A0.00Increase in Short Interest
IIAC
Investindustrial Acquisition
0.0$9.99-0.3%$501.12 millionN/A0.00
GMII
Gores Metropoulos II
0.0$10.01-0.3%$500.50 millionN/A0.00
EPHY
Epiphany Technology Acquisition
0.0$9.83-0.6%$499.36 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.0$11.03-0.2%$495.45 millionN/A0.00News Coverage
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.24-0.4%$470.22 millionN/A0.00
NGAC
NextGen Acquisition
0.0$10.00-0.1%$469.22 millionN/A0.00Increase in Short Interest
News Coverage
SPFR
Jaws Spitfire Acquisition
0.0$10.69-0.1%$461.44 millionN/A0.00
HIGA
H.I.G. Acquisition
0.0$9.98-0.2%$457.38 millionN/A0.00Decrease in Short Interest
GHVI
Gores Holdings VI
0.0$12.96-0.5%$447.12 millionN/A0.00News Coverage
LUXA
Lux Health Tech Acquisition
0.0$10.31-0.8%$441.17 millionN/A0.00Decrease in Short Interest
FSRV
FinServ Acquisition
0.0$13.67-1.3%$430.53 millionN/A0.00
CAP
Capitol Investment Corp. V
0.0$9.98-0.6%$430.39 millionN/A0.00
RMGB
RMG Acquisition Co. II
0.0$9.97-0.0%$429.96 millionN/A0.00News Coverage
GFX
Golden Falcon Acquisition
0.0$9.89-0.6%$423.92 millionN/A0.00
PCPC
Periphas Capital Partnering
0.0$24.67-0.7%$411.75 millionN/A0.00
PIAI
Prime Impact Acquisition I
0.0$9.92-0.2%$401.87 millionN/A0.00Decrease in Short Interest
NSTB
Northern Star Investment Corp. II
0.0$9.98-0.3%$400.40 millionN/A0.00
HOL
Holicity
0.0$10.57-3.1%$396.38 millionN/A0.00Increase in Short Interest
News Coverage
RAAC
Revolution Acceleration Acquisition
0.0$10.20-0.1%$391.00 millionN/A0.00
TSIA
TS Innovation Acquisitions
0.0$10.30-1.4%$386.25 millionN/A0.00Increase in Short Interest
XPOA
DPCM Capital
0.0$9.98-0.3%$385.48 millionN/A0.00Increase in Short Interest
KVSA
Khosla Ventures Acquisition
0.0$10.57-0.2%$379.46 millionN/A0.00Quiet Period Expiration
IGAC
IG Acquisition
0.0$10.00-0.4%$375 millionN/A0.00Decrease in Short Interest
PRSR
Prospector Capital
0.0$9.87-0.2%$370.13 millionN/A0.00
GMBT
Queen's Gambit Growth Capital
0.0$9.85-0.0%$369.38 millionN/A0.00
HCAR
Healthcare Services Acquisition
0.0$9.82-0.5%$353.52 millionN/A0.00News Coverage
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.